Loading stock data…
XTL Biopharmaceuticals Ltd. (XTLB)
$2.53
Market ClosedLast close Sep 8
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
XTL Biopharmaceuticals Ltd. in the Healthcare sector is trading at $2.53 with a market capitalization of $6M. The stock is currently near its 52-week low of $2.01, remaining 12.8% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 27 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 27) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q4 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Total Revenue | — | — | $289,000↑ | $162,000 | $0 |
| Gross Profit | — | — | -$43,000 | — | — |
| Operating Income | — | — | -$812,000↓ | -$764,000↓ | -$421,000 |
| Net Income | — | — | -$255,000↑ | -$553,000↑ | -$704,000 |
Peer Comparison
JNJUNHPFE
Fundamentals
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. The company's lead drug candidate is hCDR1, which is a Phase II-ready ass...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$6.22M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.45
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
404.33%
Volume
Today's trading volume
526